Effect of Rosuvastatin Therapy on Biomarkers of Inflammation and Immune Activation in People With Human Immunodeficiency Virus at Intermediate Cardiovascular Risk

Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

(2019) Steven K. Grinspoon et al.   AMERICAN HEART JOURNAL

No Evidence for an Association between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART

(2019) Roger J. Bedimo et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy

(2019) Anthony Jaworowski et al.   Frontiers in Immunology

Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency Virus

(2019) Janine M Trevillyan et al.   CLINICAL INFECTIOUS DISEASES

Monocytes from men living with HIV exhibit heightened atherogenic potential despite long-term viral suppression with antiretroviral therapy

(2019) Thomas A. Angelovich et al.   AIDS

Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV

(2016) Eric Nou et al.   AIDS

Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration

(2015) Anna Maisa et al.   AIDS

Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy

(2015) Nicholas T. Funderburg et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Tenofovir/Emtricitabine/Efavirenz Plus Rosuvastatin Decrease Serum Levels of Inflammatory Markers More Than Antiretroviral Drugs Alone in Antiretroviral Therapy-Naive HIV-Infected Patients

(2014) Leonardo Calza et al.   HIV CLINICAL TRIALS

The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case–control study

(2013) Andrea De Luca et al.   BMC INFECTIOUS DISEASES

High‐Density Lipoprotein Particles and Markers of Inflammation and Thrombotic Activity in Patients with Untreated HIV Infection

(2009) Jason Baker et al.   JOURNAL OF INFECTIOUS DISEASES

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

HMG-CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation

(2008) J.E. Fildes et al.   TRANSPLANT IMMUNOLOGY